Latest Articles
Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial - Nature.com
Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial Nature.com
Published: Feb. 20, 2025, 9:18 p.m.
Ananda Pharma's MRX1 moves closer to clinical trials after key milestone - Proactive Investors UK
Ananda Pharma's MRX1 moves closer to clinical trials after key milestone Proactive Investors UK
Published: Feb. 20, 2025, 3:20 p.m.
Karyopharm Therapeutics Inc. SEC 10-K Report - TradingView
Karyopharm Therapeutics Inc. SEC 10-K Report TradingView
Published: Feb. 19, 2025, 12:38 p.m.
‘Farmers generally don’t ask for help’: Primary producers plea - Courier Mail
‘Farmers generally don’t ask for help’: Primary producers plea Courier Mail
Published: Feb. 17, 2025, 3:29 a.m.
First look: Multimillion-dollar upgrade to transform rural hospital - Townsville Bulletin
First look: Multimillion-dollar upgrade to transform rural hospital Townsville Bulletin
Published: Feb. 16, 2025, 11:30 p.m.
Deadly Winter Storms Overwhelm Creeks, Knock Out Power Across Kentucky - Townsville Bulletin
Deadly Winter Storms Overwhelm Creeks, Knock Out Power Across Kentucky Townsville Bulletin
Published: Feb. 16, 2025, 8:56 p.m.
Hezbollah supporters clash with Lebanese army in Beirut - Townsville Bulletin
Hezbollah supporters clash with Lebanese army in Beirut Townsville Bulletin
Published: Feb. 16, 2025, 8:41 a.m.
Gen Z Woman's Worst Fears Confirmed After 8 Year Struggle for Diagnosis - Newsweek
Gen Z Woman's Worst Fears Confirmed After 8 Year Struggle for Diagnosis Newsweek
Published: Feb. 15, 2025, noon
Tens of Thousands Without Power in Virginia After Storms Down Lines - Townsville Bulletin
Tens of Thousands Without Power in Virginia After Storms Down Lines Townsville Bulletin
Published: Feb. 13, 2025, 6:40 p.m.
Gesynta Pharma Receives $27 M For Endometriosis Novel Therapy Drug - Forbes
Gesynta Pharma Receives $27 M For Endometriosis Novel Therapy Drug Forbes
Published: Feb. 13, 2025, 5:04 p.m.
Link copied to clipboard!